Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.
about
Anti-HIV-1 nanotherapeutics: promises and challenges for the futureInvolvement of long noncoding RNAs in diseases affecting the central nervous systemNanostructures: a platform for brain repair and augmentationMonocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue - Evaluations on Monocyte-Based Delivery System for the Central Nervous SystemSynthetic Nanoparticles for Vaccines and ImmunotherapyCell delivery of therapeutic nanoparticlesActivation of latent HIV using drug-loaded nanoparticlesCellular Responses and Tissue Depots for Nanoformulated Antiretroviral TherapyNanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Nanotechnology and HIV: potential applications for treatment and prevention.Progress in antiretroviral drug delivery using nanotechnologyIrradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for Cancer Therapy.In vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsionsNanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsHIV-1 neuroimmunity in the era of antiretroviral therapy.HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrierMacrophage delivery of therapeutic nanozymes in a murine model of Parkinson's diseaseHIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.Co-opting biology to deliver drugsTowards nanomedicines for neuroAIDS.Optimal structural design of mannosylated nanocarriers for macrophage targeting.Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophagesRegistered bioimaging of nanomaterials for diagnostic and therapeutic monitoring.Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages.Cell-mediated drug delivery.Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesNatural antisense transcripts as therapeutic targetsTranslational challenges in targeting latent HIV infection and the CNS reservoir problem.Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophagesType and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes.Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells.
P2860
Q26828464-5C7D211A-28D3-46A3-AB45-14671EA79C2BQ26852160-57098BA0-084D-4A72-8953-D933245C0068Q27010023-DD113FF2-F946-4EA6-BD66-426259EE6D0BQ27312829-2E5633FD-A222-4D9A-B01F-C43D175662C5Q28085375-46EA4604-4E60-4D5B-B8BC-5DA35A614F68Q28385606-972C9D0D-0912-4927-94FE-D37838A2700FQ28477657-03822A4E-0A18-4C56-9AD9-ACA821747663Q28551873-68C7C289-E98B-4750-95C3-030EB261423EQ30387307-506F0C0E-3D26-4FDD-A0E5-0DA95D2FF66FQ30393980-1760607A-AF98-4F1C-91E7-F876A7517B98Q30395011-D25268C5-4673-429D-8FE6-7919BE0D5565Q30401659-E79B4205-1D00-490C-A1C8-9F33B59961BCQ30469832-BBD82AE6-77A6-4BE9-88E6-79055D570AC9Q30493643-852BCF70-C275-414E-A8FB-FF18D709B71BQ30603781-8ADD25D3-FE15-4636-95BD-0A984B6FC87CQ33614467-877289A7-02B6-4E36-A25C-F8EBB5155C63Q33733529-B91FCDCA-4AC0-4C73-9E9C-749BE6C31259Q33805298-AEC5B5DE-7959-4462-8FC9-EF929C365281Q33819656-02DBC527-1451-4664-B059-7A50560DF4A9Q33831400-1415DE18-1345-4D0A-B4D6-3904A71E4605Q33892744-C4E20154-4B7D-4028-A919-9872F408CEA5Q34037622-388121EB-B2C0-4D24-B69A-64C5E0248EA5Q34059457-2FA6B158-1FD7-4558-96E1-66DB11618A86Q34079604-FC532D66-D7C7-4E17-B7AA-4F74F5FAC00DQ34424045-50480550-2D2F-43E6-9D79-EE5B3C0BB383Q34495140-9CA6CB9B-924F-47D2-9DD4-6B8BB28E5B5FQ34623115-5C7726EF-7651-476D-BD1D-41A5A6989946Q34632979-559DB4F7-168B-41D0-B595-169BC86C23D6Q34639915-FB8CC3D6-43D2-484F-A298-7296AFFA6106Q34639923-590CB40F-BAAB-451F-87D7-3102E6F20E5EQ34641722-CDB193E9-A5E8-4BDE-9431-5C3753841582Q34709440-73D00E52-E80C-4918-8C52-96C512AFC5D3Q34728884-13CA2866-53F6-4B6F-AEFA-001A31236C2BQ34797004-BBF59372-A1BE-49C9-BF43-8222A3C943B2Q34859292-0E115F57-7440-4A02-A972-AA79DAFCB57BQ35009744-3BE29591-1143-48D0-A6E0-37FB679CDB6DQ35016131-4A3E8F05-0D48-4205-853C-0D0CFFEC063CQ35071617-23187434-D9CF-4F65-BCC4-86A2C70DA994Q35088011-A78FDA70-42EC-4EB0-943B-B9F84D77544FQ35194750-CAA3DC39-8975-4D06-82BC-2CA11579067A
P2860
Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.
@en
Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.
@nl
type
label
Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.
@en
Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.
@nl
prefLabel
Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.
@en
Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.
@nl
P2093
P2860
P921
P356
P1476
Macrophage delivery of nanofor ...... n a murine model of neuroAIDS.
@en
P2093
Barrett Rabinow
Cassi B Grotepas
Howard E Gendelman
Huanyu Dou
James Kipp
Jane Werling
JoEllyn M McMillan
Mahesh Chaubal
P2860
P304
P356
10.4049/JIMMUNOL.0900274
P407
P577
2009-06-17T00:00:00Z